On Monitoring Devices for glucose in critical patients during the COVID-19 pandemic
An update on International Evidence
DOI:
https://doi.org/10.56226/ihr.v1i2.29Keywords:
Continuous glucose monitoring, Glucose management, intensive care unit, COVID-19, monitoring devicesAbstract
Background: Hyperglycemia is common in Intensive Care Unit (ICU) and was reported with high mortality and adverse patients’ outcomes. The infection of COVID-19 is identified as a main source of increase in the incidence of hyperglycemia and associated elevated mortality. In order to reduce the healthcare providers exposure and the personal protective equipment use during the pandemic, the US Food and Drug Administration (FDA) regulated the usage of continuous glucose monitoring (CGM) devices to address these concerns as well as control the glucose level at a desired range. What are the benefits of using CGM applications? The article updates knowledge on this topic.
Methods:We did our search on the following databases: MEDLINE, EMBASE and Cochrane database, articles included were all recent and between January 2020 to July 2022. Our main focus was on articles with evidence concerning the effectiveness and the accuracy of continuous blood glucose monitoring methods in ICU during the COVID-19 pandemic.
Results: A few recent articles were identified and scrutinized. These allow the article to present an overview of the most recent international evidence on the topic, ts benefits and a comparison between methods and devices.
Main Contribution to Evidence-Based Practice: The article puts together the most recent evidence on the demonstrated benefits of continuous glucose monitoring and identifies the few glucose Monitoring Devices about which there is recent published scientific evidence on its application to critical care.
References
Agarwal, S., Mathew, J., Davis, G. M., Shephardson, A., Levine, A., Louard, R., . . . Pasquel, F. J. (2021). Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic. Diabetes Care, 44(3), 847-849. doi:10.2337/dc20-2219 DOI: https://doi.org/10.2337/dc20-2219
Antunes, V. (2022). On Nursing Research and Evidence-Based Practice: Topics for researchers and practitioners. International Healthcare Review (online), 1(1). https://doi.org/10.56226/ihr.v1i1.12 DOI: https://doi.org/10.56226/ihr.v1i1.12
Chow, K. W., Kelly, D. J., Gupta, R., & Miller, J. D. (2021). Use of Continuous Glucose Monitoring to Assess Parenteral Nutrition-Induced Hyperglycemia in an Adult Patient With Severe COVID-19. JPEN J Parenter Enteral Nutr, 45(1), 208-211. doi:10.1002/jpen.2032 DOI: https://doi.org/10.1002/jpen.2032
Chow, K. W., Kelly, D. J., Rieff, M. C., Skala, P. A., Kravets, I., Charitou, M. M., . . . Miller, J. D. (2021). Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU. J Diabetes Sci Technol, 15(3), 607-614. doi:10.1177/1932296820985263 DOI: https://doi.org/10.1177/1932296820985263
Davis, G. M., Faulds, E., Walker, T., Vigliotti, D., Rabinovich, M., Hester, J., . . . Pasquel, F. J. (2021). Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept. Diabetes Care, 44(4), 1055-1058. doi:10.2337/dc20-2085 DOI: https://doi.org/10.2337/dc20-2085
Faulds, E. R., Boutsicaris, A., Sumner, L., Jones, L., McNett, M., Smetana, K. S., . . . Dungan, K. (2021). Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study. J Clin Endocrinol Metab, 106(10), e4007-e4016. doi:10.1210/clinem/dgab409 DOI: https://doi.org/10.1210/clinem/dgab409
Longo, R. R., Elias, H., Khan, M., & Seley, J. J. (2021). Use and Accuracy of Inpatient CGM During the COVID-19 Pandemic: An Observational Study of General Medicine and ICU Patients. J Diabetes Sci Technol, 19322968211008446. doi:10.1177/19322968211008446 DOI: https://doi.org/10.1177/19322968211008446
Perez-Guzman, M. C., Duggan, E., Gibanica, S., Cardona, S., Corujo-Rodriguez, A., Faloye, A., . . . Pasquel, F. J. (2021). Continuous Glucose Monitoring in the Operating Room and Cardiac Intensive Care Unit. Diabetes Care, 44(3), e50-e52. doi:10.2337/dc20-2386 DOI: https://doi.org/10.2337/dc20-2386
Sadhu, A. R., Serrano, I. A., Xu, J., Nisar, T., Lucier, J., Pandya, A. R., & Patham, B. (2020). Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study. J Diabetes Sci Technol, 14(6), 1065-1073. doi:10.1177/1932296820964264 DOI: https://doi.org/10.1177/1932296820964264
Sardu, C., D'Onofrio, N., Balestrieri, M. L., Barbieri, M., Rizzo, M. R., Messina, V., . . . Marfella, R. (2020). Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care, 43(7), 1408-1415. doi:10.2337/dc20-0723 DOI: https://doi.org/10.2337/dc20-0723
van Steen, S. C., Rijkenberg, S., Limpens, J., van der Voort, P. H., Hermanides, J., & DeVries, J. H. (2017). The Clinical Benefits and Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients-A Systematic Scoping Review. Sensors (Basel), 17(1). doi:10.3390/s17010146 DOI: https://doi.org/10.3390/s17010146
Yao, R. Q., Ren, C., Wu, G. S., Zhu, Y. B., Xia, Z. F., & Yao, Y. M. (2020). Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis. Int J Biol Sci, 16(9), 1658-1675. doi:10.7150/ijbs.43447 DOI: https://doi.org/10.7150/ijbs.43447
Zhu, L., She, Z. G., Cheng, X., Qin, J. J., Zhang, X. J., Cai, J., . . . Li, H. (2020). Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab, 31(6), 1068-1077.e1063. doi:10.1016/j.cmet.2020.04.021 DOI: https://doi.org/10.1016/j.cmet.2020.04.021

Downloads
Published
How to Cite
License
Copyright (c) 2022 The Publisher

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.